Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

BioChem Pharma describes lactams for thrombotic disorders

June 23, 1998

Eisai launches monteplase in first market

June 16, 1998

Bayer seeks FDA approval for improved second-generation hemophilia A product

June 12, 1998

Targeted NO donor enhances the activity of aspirin and heparin in preventing embolization

June 8, 1998

Avigen and Cell Genesys report success with gene therapy of hemophilia B

June 2, 1998

Emisphere Technologies begins phase II trial with oral heparin

June 1, 1998

Integrilin launched in first market today

June 1, 1998

Schering AG presents factor Xa/thrombin inhibitors

June 1, 1998

New antiplatelet agents prepared by Sankyo/Ube researchers

May 29, 1998

P2T purinoceptor receptor antagonists with platelet antiaggregatory activity

May 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.